Estimating Clinical Morbidity Due to Ischemic Heart Disease and Congestive Heart Failure: the Future Rise of Heart Failure

Overview

Journal Am J Public Health

Specialty Public Health

Date 1994 Jan 1

PMID 8279606

Citations 62

Authors

L Bonneux

J J Barendregt

K Meeter

G J Bonsel

P J van der Maas

Affiliations

Soon will be listed here.

Abstract

Objectives: Many developed countries have seen declining mortality rates for heart disease, together with an alleged decline in incidence and a seemingly paradoxical increase in health care demands. This paper presents a model for forecasting the plausible evolution of heart disease morbidity.

Methods: The simulation model combines data from different sources. It generates acute coronary event and mortality rates from published data on incidences, recurrences, and lethalities of different heart disease conditions and interventions. Forecasts are based on plausible scenarios for declining incidence and increasing survival.

Results: Mortality is postponed more than incidence. Prevalence rates of morbidity will decrease among the young and middle-aged but increase among the elderly. As the milder disease states act as risk factors for the more severe states, effects will culminate in the most severe disease states with a disproportionate increase in older people.

Conclusions: Increasing health care needs in the face of declining mortality rates are no contradiction, but reflect a tradeoff of mortality for morbidity. The aging of the population will accentuate this morbidity increase.

Citing Articles

The Role of Inflammasomes in Heart Failure.

Vlachakis P, Theofilis P, Kachrimanidis I, Giannakopoulos K, Drakopoulou M, Apostolos A Int J Mol Sci. 2024; 25(10).

PMID: 38791409 PMC: 11121241. DOI: 10.3390/ijms25105372.

Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction.

Khan M, Aslam Soomro N, Naseeb K, Bhatti U, Rauf R, Balouch I BMC Cardiovasc Disord. 2023; 23(1):133.

PMID: 36915075 PMC: 10012729. DOI: 10.1186/s12872-023-03070-9.

The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports.

Yazdanpanah M, Bahramali E, Kazemi M, Firouzabadi N, Arasteh P, Homayounfar R Galen Med J. 2022; 10:e2111.

PMID: 35620276 PMC: 9107350. DOI: 10.31661/gmj.v10i0.2111.

Utilization of Risk Scores for Coronary Heart Disease Diagnosis in Rural China.

Liao H, Chen Q, Liu L, Zhong S, Xiao C Int J Gen Med. 2022; 15:2541-2548.

PMID: 35282649 PMC: 8907025. DOI: 10.2147/IJGM.S355573.

A review of smart sensors coupled with Internet of Things and Artificial Intelligence approach for heart failure monitoring.

Maurya M, Riyaz N, Bhargava Reddy M, Yalcin H, Ouakad H, Bahadur I Med Biol Eng Comput. 2021; 59(11-12):2185-2203.

PMID: 34611787 DOI: 10.1007/s11517-021-02447-2.

References

DeBusk R, Kraemer H, Nash E, Berger 3rd W, Lew H . Stepwise risk stratification soon after acute myocardial infarction. Am J Cardiol. 1983; 52(10):1161-6. DOI: 10.1016/0002-9149(83)90567-2. View

Reunanen A, Aromaa A, Pyorala K, PUNSAR S, Maatela J, Knekt P . The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl. 1983; 673:1-120. View

Goldman L, Cook E . The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984; 101(6):825-36. DOI: 10.7326/0003-4819-101-6-825. View

HOOGENDOORN D . [Atherosclerotic heart diseases in the hospital and in the cause-of-death statistics]. Ned Tijdschr Geneeskd. 1985; 129(38):1827-33. View

DeBusk R, Blomqvist C, Kouchoukos N, Luepker R, Miller H, MOSS A . Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med. 1986; 314(3):161-6. DOI: 10.1056/NEJM198601163140307. View

Fioretti P, Tijssen J, Azar A, Lazzeroni E, Brower R, ten Katen H . Prognostic value of predischarge 12 lead electrocardiogram after myocardial infarction compared with other routine clinical variables. Br Heart J. 1987; 57(4):306-12. PMC: 1277168. DOI: 10.1136/hrt.57.4.306. View

Weinstein M, Coxson P, Williams L, Pass T, Stason W, Goldman L . Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987; 77(11):1417-26. PMC: 1647098. DOI: 10.2105/ajph.77.11.1417. View

Kaul S, Lilly D, Gascho J, WATSON D, Gibson R, Oliner C . Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation. 1988; 77(4):745-58. DOI: 10.1161/01.cir.77.4.745. View

Brook R, Kosecoff J, Park R, Chassin M, Winslow C, Hampton J . Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet. 1988; 1(8588):750-3. DOI: 10.1016/s0140-6736(88)91550-4. View

10.

Uemura K . International trends in cardiovascular diseases in the elderly. Eur Heart J. 1988; 9 Suppl D:1-8. DOI: 10.1093/eurheartj/9.suppl_d.1. View

11.

Winslow C, Kosecoff J, Chassin M, Kanouse D, Brook R . The appropriateness of performing coronary artery bypass surgery. JAMA. 1988; 260(4):505-9. View

12.

Ahnve S, Gilpin E, DITTRICH H, NICOD P, Henning H, Carlisle J . First myocardial infarction: age and ejection fraction identify a low-risk group. Am Heart J. 1988; 116(4):925-32. DOI: 10.1016/0002-8703(88)90142-1. View

13.

van Domburg R, van den Brand M, Lubsen J, Bos E, Hugenholtz P . [Incidence and results of re-interventions following coronary vessel surgery]. Ned Tijdschr Geneeskd. 1988; 132(51):2316-20. View

14.

Mackenbach J, Looman C, Kunst A, Habbema J, van der Maas P . Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med. 1988; 27(9):889-94. DOI: 10.1016/0277-9536(88)90278-x. View

15.

Uemura K, PISA Z . Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988; 41(3-4):155-78. View

16.

Kannel W . Epidemiological aspects of heart failure. Cardiol Clin. 1989; 7(1):1-9. View

17.

Glazier J, Varricchione T, Ryan T, Ruocco N, Jacobs A, Faxon D . Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. Br Heart J. 1989; 61(6):485-8. PMC: 1216703. DOI: 10.1136/hrt.61.6.485. View

18.

Detre K, Holubkov R, Kelsey S, Bourassa M, Williams D, Holmes Jr D . One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1989; 80(3):421-8. DOI: 10.1161/01.cir.80.3.421. View

19.

HOOGENDOORN D . [Frequency and surgical mortality in surgery of the heart and of the intrathoracic large vessels. I. Direct coronary revascularizations]. Ned Tijdschr Geneeskd. 1989; 133(49):2445-8. View

20.

Weintraub W, Jones E, King 3rd S, Craver J, Douglas Jr J, Guyton R . Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. Am J Cardiol. 1990; 65(3):183-8. DOI: 10.1016/0002-9149(90)90082-c. View